personalized, responsive service and to improve the site, we remember and store information about how you use
Congratulations! You now have unlimited access to all articles from The Medicine Maker.
Complete your profile at your earliest convenience to unlock the rest of your benefits:
relevant and personalised updates about your field
access to White Papers/product profiles
digital magazine subscription
The Medicine Maker
Welcome to the February issue. Upfront covers an implantable neural device that can deliver drugs with great accuracy, and a study on the inclusion of women in clinical trials. David Harry explains why pharma companies will increasingly rely on software to keep all of their balls in the air in In My View. Our cover feature delves in to the deep waters of biopharmaceutical analysis with four analytical experts as your guide. In Business, we look at how Brexit could impact pharma supply chains, and in Best Practice Adrian Carter calls for pharma to embrace the crowdsourcing phenomenon. Finally, we Sit Down With Nigel Darby of GE Healthcare to discuss destroying saucepans, moving from research to industry, and the rise of biopharmaceuticals.